Home > Result Summaries: Compounds > Human Papillomavirus Types 16 and 18 Vaccine > Result Summary for 107863

Result Summary for 107863

Result Summary

Protocol ID:	107863
Clinical Study ID:	107863
Official Title:	Evaluation of the safety and immunogenicity of GlaxoSmithKline Biologicals' HPV vaccine 580299 (Cervarix TM) in adult human immunodeficiency virus (HIV) infected female subjects
Phase:	phase 2
Study Indications or Diseases:	Human Papillomavirus (HPV)
Generic Name:	Human Papillomavirus Types 16 and 18 Vaccine
Trade/Product Name:	Cervarix
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Denny L et al. Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa M12 results. Abstract presented at the 20th World Congress of Gynecology & Obstetrics (FIGO), Rome, Italy, 7-12 October 2012. Denny L et al. Safety and immunogenicity of the HPV16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa. Abstract presented at the African Organisation for Research and Training in Cancer (AORTIC). Cairo, Egypt, November 30 – December 3, 2011.